Glafenine

Glafenine
Clinical data
ATC code	N02BG03 (WHO) ;
Identifiers
	IUPAC name 2,3-Dihydroxypropyl 2-[(7-chloro-4-quinolinyl)amino]benzoate;
CAS Number	3820-67-5;
PubChem CID	3474;
ChemSpider	3355;
ChEBI	CHEBI:31653 ;
ChEMBL	ChEMBL146095;
CompTox Dashboard (EPA)	DTXSID1048546 ;
ECHA InfoCard	100.021.197
Chemical and physical data
Formula	C19H17ClN2O4
Molar mass	372.802 g/mol g·mol−1
3D model (JSmol)	Interactive image;
Melting point	169 to 170 °C (336 to 338 °F)
	SMILES O=C(OCC(O)CO)c1ccccc1Nc2c3ccc(Cl)cc3ncc2;
	InChI InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22); Key:GWOFUCIGLDBNKM-UHFFFAOYSA-N;

Glafenine is a nonsteroidal anti-inflammatory drug (NSAID). Use of glafenine is limited due to the risk of anaphylaxis and acute kidney failure.[1][2]

References

"Withdrawal of glafenine". The Lancet. 339 (8789): 357. 1992. doi:10.1016/0140-6736(92)91670-4.
Kleinknecht, D; Landais, P; Goldfarb, B (1986). "Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: A prospective collaborative study". Clinical nephrology. 25 (6): 275–81. PMID 2873910.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.